AMICUS THERAPEUTICS, INC. — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5cb5b82e-6f86-4ba2-b23d-460df55487cc/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $32.8M | 2025-01-01 – 2025-12-31 | evidence 0001178879-26-000005 |
| FY 2024 | $24.9M | 2024-01-01 – 2024-12-31 | evidence 0001178879-25-000003 |
| FY 2023 | $-77.2M | 2023-01-01 – 2023-12-31 | evidence 0001178879-24-000003 |
| FY 2022 | $-212.1M | 2022-01-01 – 2022-12-31 | evidence 0001178879-23-000004 |
| FY 2021 | $-206.4M | 2021-01-01 – 2021-12-31 | evidence 0001178879-22-000006 |
| FY 2020 | $-247.0M | 2020-01-01 – 2020-12-31 | evidence 0001178879-21-000004 |
| FY 2019 | $-304.0M | 2019-01-01 – 2019-12-31 | evidence 0001178879-20-000015 |
| FY 2018 | $-328.8M | 2018-01-01 – 2018-12-31 | evidence 0001178879-19-000024 |
| FY 2017 | $-442.0M | 2017-01-01 – 2017-12-31 | evidence 0001047469-18-001199 |
| FY 2016 | $-181.9M | 2016-01-01 – 2016-12-31 | evidence 0001047469-17-001128 |
| FY 2015 | $-130.4M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010563 |
| FY 2014 | $-68.7M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001585 |
| FY 2013 | $-421.2M | 2002-02-04 – 2014-03-31 | evidence 0001104659-14-034647 |
| FY 2012 | $-358.6M | 2002-02-04 – 2013-03-31 | evidence 0001104659-13-039699 |
| FY 2011 | $-299.2M | 2002-02-04 – 2012-03-31 | evidence 0001104659-12-036030 |
| FY 2010 | $-55.8M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-085717 |
| FY 2009 | $-7.3M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-085717 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AMICUS THERAPEUTICS, INC. — all facts · Revenue · Net Income